A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

A new pill is helping people with Type 2 diabetes lose weight and lower blood sugar in a phase-three clinical trial.

Eli Lilly shares jumped 15% after a clinical trial ... which regulates appetite, insulin secretion, and blood sugar. While originally developed to treat Type 2 diabetes, GLP-1 drugs have surged ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical ... GLP-1 drugs mimic a hormone called glucagon-like peptide 1 by creating more insulin to help lower blood sugar, which ...

Eli Lilly's Phase 3 study highlights the effectiveness ... these medications manage blood sugar levels by triggering insulin release from the pancreas. The drugs also help slow digestion, which ...

Drugmaker Eli Lilly said Thursday that an experimental ... People who have diabetes can’t make enough insulin, a hormone the pancreas makes to help the body keep blood sugar levels in a certain ...